A nail in the coffin of troponin measurements after percutaneous coronary intervention

Journal of the American College of Cardiology

Volumn 57, Issue 6, 2011, Pages 662-663

  Grines, Cindy L ^a   Dixon, Simon ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

biomarkers; myocardial infarction; PCI; prognosis; stent; troponin

Indexed keywords

CREATINE KINASE MB; TROPONIN I;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ELECTROCARDIOGRAPHY; HEART INFARCTION SIZE; HIGH RISK POPULATION; HUMAN; NOTE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL;

EID: 79551556854     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.09.045     Document Type: Editorial

References (18)

1. P. Cummins, and S.V. Perry Troponin 1 from human skeletal and cardiac muscles Biochem J 171 1978 251 259
2. J.S. Alpert, K. Thyestean, E. Antman, and J.P. Bassand Myocardial infarction redefineda consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee J Am Coll Cardiol 36 2000 959 969
3. E. Antman, M. Tanasijevic, and B. Thompson Cardiac-specific troponin 1 levels to predict the risk of mortality in patients with acute coronary syndromes N Engl J Med 335 1996 1342 1349
4. A.E. Arai False positive or true positive troponin in patients presenting with chest pain but 'normal' coronary arteries: lesions from cardiac MRI Eur Heart J 28 2007 1175 1177
5. G. Lum, D.E. Solarz, and L. Farney False positive cardiac troponin results in patients without acute myocardial infarction Lab Med 37 2006 546 550
6. U.S. Food and Drug Administration Medical Devices. "Troponin: What laboratories should know to manage elevated results." http://www.fda.gov/ MedicalDevices/Safety/AltertsandNotices/TipsandArticlesonDeviceSafety/ucm109362. htm Accessed August 16, 2010
7. M.B. Nienhuis, J.P. Ottervanger, H.J.G. Bilo, B.D. Dikkeschei, and F. Zijlstra Prognostic value of troponin after elective percutaneous coronary intervention: a meta-analysis Cath Cardiovasc Intervent 71 2008 318 324
8. J.R. Kizer, M.R. Muttrej, and W.H. Matthai Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention Eur Heart J 24 2003 1314 1322
9. W.J. Cantor, K. Newby, and R.H. Christenson Prognostic significance of elevated troponin I after percutaneous coronary intervention J Am Coll Cardiol 39 2002 1738 1744
10. A.S. Kini, P. Lee, and J.D. Marmur Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality Am J Cardiol 93 2004 18 23
11. L. Bonello, A. DeLabriolle, and G. Lemesle Prognostic value of procedure-related myocardial infarction according to the universal definition of myocardial infarction in saphenous vein graft interventions Am Heart J 157 2009 894 898
12. J. Hubacek, R.S. Basran, F.M. Shrive, L. Shewchuk, D.M. Goodhart, and T.J. Anderson Prognostic implications of C-reactive protein and troponin following percutaneous coronary intervention Can J Cardiol 25 2009 e42 e47
13. A. Prasad, B.J. Gersh, and M.E. Bertrand Prognostic significance of per procedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial J Am Coll Cardiol 55 2010 503 504
14. D.A. Morrow Clinical application of sensitive troponin assays N Engl J Med 361 2009 913 915
15. P.A. Kavsak, A.R. MacRae, and V. Lustig The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction Am Heart J 152 2006 118 125
16. G.A. Diamond, and S. Kaul How would the Reverend Bayes interpret high-sensitivity troponin? Circulation 121 2010 1172 1175
17. T.Y. Wang, E.D. Peterson, and D. Dai Patterns of cardiac marker surveillance after elective percutaneous coronary intervention and implications for the use of per procedural myocardial infarction as a quality metric: a report from the National Cardiovascular Data Registry (NCDR) J Am Coll Cardiol 51 2008 2068 2074
18. C.C.S. Lim, W.J. van Gaal, and L. Testa With the "universal definition," measurement of creatine kinase myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention J Am Coll Cardiol 57 2011 653 661